Quetiapine Fumarate
Product Images NDC 68151-5225

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 68151-5225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681515225)

Label for Quetiapine Fumarate Extended-Release 50 mg tablet. The label shows dosing as once daily tablet and includes manufacturing details from PHARMDAX. It lists a lot number, expiration date (03/18), and an NDC code 52817-160-60. The label indicates 'Rx Only' and includes a barcode and a product identifier number 0000005225.*

FDA Label Image

Figure-1 (Qaffigure 1)

A line graph comparing the proportion of patients with relapse (%) over time in months between two groups: PLA (placebo) shown with a dashed line, and QTP XR (Quetiapine Extended Release) shown with a solid line. The QTP XR group shows a lower relapse proportion over approximately 7 months.*

FDA Label Image

Figure-2 (Qaffigure 2)

A Kaplan-Meier relapse curve showing the proportion of patients with relapse (%) plotted against time (weeks) up to 100 weeks. Two groups are compared: one treated with Quetiapine (QTP) plus Lithium/Valproate (LI/VAL) indicated with a dashed line, and the other with Placebo (PLA) plus Lithium/Valproate (LI/VAL) indicated with a solid line. The PLA+LI/VAL group shows a higher proportion of relapse over time compared to the QTP+LI/VAL group.*

FDA Label Image

Figure-3 (Qaffigure 3)

A line chart showing the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two lines are plotted: a solid line for PLA+LI/VAL and a dashed line for QTP+LI/VAL, indicating different relapse rates between these groups over the study period.*

FDA Label Image

Structure (Qafstructure)

Chemical structure diagram showing the molecular structure of Quetiapine Fumarate, including the bicyclic thiazepine ring system and the fumarate counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.